Modulation of the humoral immune response by placental secretory factors

American Journal of Reproductive Immunology

Volumn 35, Issue 6, 1996, Pages 529-533

  Borel, Ileana Malan ^b   Miranda, Silvia ^b   Freire, Songeli Menezes ^b   Canellada, Andrea ^b   Bueno, Marta Eslava ^b   Binaghi, Ruben ^b   Margni, Ricardo A ^a  

^a Instituto de Estudios de la Inmunidad Humoral   (Argentina)

^b NONE

Author keywords

Antibody synthesis; Human placenta; Placental factors

Indexed keywords

IMMUNOGLOBULIN G1; MONOCLONAL ANTIBODY; TRITIUM;

ALLOGRAFT; ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; HYBRIDOMA; IMMUNOMODULATION; MOUSE; NONHUMAN; PLACENTA; PRIORITY JOURNAL;

EID: 0029954861     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.1996.tb00053.x     Document Type: Article

References (23)

1. Duc HT, Kinsky RG, Kanellopoulos J, Voisin GA. Biologic properties of transplantation immune sera IV. Influence of the course of immunization, dilution and complexing to antigen on enhancing activity of Ig classes. J Immunol 1975; 115:1143-1149.
2. Hamilton MS. Cell mediated immunity to embryonic antigens of syngeneically and allogeneically mated mice. Transplantation 1976; 21:261-263.
3. Hellstrom KE, Hellstrom I. Lymphocyte-mediated cytotoxicity and blocking serum. Activity tumor antigens. Adv Immunol 1974; 18:209-213.
4. Clark DA, Damji N, Chaput A, Daya S, Rosenthal KL, Brierley J. Trophoblast-dependent and trophoblast-independent suppressor cells of maternal origin in murine and human decidua. Prog Immunol IV 1986; 00:1089-1099.
5. Ellis SA, Palmer MS, McMichael AJ. Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA class I molecule. J Immunol 1990; 144:731-735.
6. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, De-Mars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990; 248:220-223.
7. Sargent IL. Maternal and fetal immune responses during pregnancy. Exp Clin Immunogenet 1993; 10:85-102.
8. King A, Loke YW. Human trophoblast and JEG choriocarcinoma cells are sensitive to lysis by IL-2 stimulated decidual NK cells. Cell Immunol 1990; 129:435-448.
9. Bitoh S, Yamamoto H. Immunological suppressive mechanisms at the early stage of embryogenesis. Reprod Immun Materno-Fetal Relationship Colloque. INSERM. 1987; 154:121-130.
10. Barg M, Burton RC, Smith JA, Luckenbach GA, Decker J, Mitchell GF. Effect of placental tissue on immunological responses. Clin Exp Immunol 1978; 34:441-448.
11. Chaouat G, Kolb J. Immunoactive products of placenta. IV. Impairement by placental cells and their products of CTL function at effector stage. J Immunol 1985; 135:215-222.
12. Chaouat G, Kolb J, Chaffoux S, Riviere M, Lankar D, Athanassakis I, Green D, Wegmann TG. The placenta and the survival of the fetal allograft. In Immunoregulation and Fetal Survival, TJ Gill III, TG Wegmann (eds), New York, Oxford University Press, 1987, pp 239-251.
13. Chaouat G. Placental immunoregulatory factors. J Reprod Immunol 1987; 10:179-188.
14. Malan Borel I, Gentile T, Angelucci J, Pividori J, Guala M, Binaghi R, Margni RA. IgG asymmetric molecules with anti-parternal activity isolated from sera and placenta of pregnant human. J Reprod Immunol 1991; 20:129-140.
15. Margni RA, Binaghi RA. Nonprecipitating asymmetric antibodies. Ann Rev Immunol 1988; 6:535-554.
16. Margni RA, Malan Borel I, Kapovic M, Angelucci J, Miranda S, Kinsky R, Chaouat G. The proportion of symmetric and asymmetric IgG antibody molecules synthesized by a cellular clone (hybridoma) can be regulated by placental culture supernatants. Cell Immunol 1992; 142:287-295.
17. Menu E, Kaplan L, Andreu G, Denver L, Chaouat G. Immunoactive products of human placenta and immunoregulatory factors obtained from expiant cultures of human placenta inhibit CTL generation and cytotoxic effector activity. Cell Immunol 1989; 119:341-352.
18. Morelli L, Leoni J, Fossati CA, Margni RA. Symmetric and asymmetric IgG antibodies are synthesized by the same cellular clone. Mol Immunol 1989; 26:789-792.
19. Koller G, Milstein C. Continuous culture of fused cells secreting antibodies of predesigned specificity. Nature 1975; 256:495-497.
20. Engvall E, Perlmann P. Enzyme-linked immunoadsorbent assay (ELISA): quantitative assay of immunoglobulin G. Immunochemistry 1972; 8:871-879.
21. Labeta M, Margni RA, Leoni J, Binaghi R. Structure of asymmetric nonprecipitating antibodies: presence of a carbohydrate residue in only one Fab region of the molecule. Immunology 1986; 57:311-317.
22. Margni RA. Are the nonprecipitating asymmetric antibodies autoprotective and regulatory antibodies? One opinion. Res Immunol (Inst. Pasteur) 1989; 140:725-729.
23. Margni RA. Coprecipitating IgG asymmetric antibodies: a possible role for Fab glycosylation, and speculations on their formation and functions in disease. Glycosyl Dis 1994; 1:59-66.